Renishaw (RSW) CMD 2025 summary
Event summary combining transcript, slides, and related documents.
CMD 2025 summary
13 Nov, 2025Strategic Direction and Innovation
Focus sharpened on core markets after exiting drug delivery and neurosurgery, aiming to be a manufacturing technology powerhouse for automated, sustainable solutions.
Accelerated innovation is driving revenue growth, with new products like high-end laser encoders, Tempest technology, Equator X system, and MODUS IM software targeting high-growth sectors.
Product development emphasizes minimum viable products, rapid market entry, and iterative improvement based on customer feedback, with flagship projects for each product line.
Capital investments in automation and new production capacity support growth without increasing direct labor, enhancing productivity and cost efficiency.
Strategic priorities include growing existing markets, increasing technology value, expanding into new markets (especially Asia), and responsible business practices.
Financial Guidance and Operational Targets
Targeting high single-digit organic growth, a return to over 20% adjusted operating margin, and ROIC above 15%.
Gross margin has declined from 65% to 61% due to labor cost inflation; initiatives underway to reduce labor content and improve productivity.
Fixed cost reduction program aims to cut payroll by £20 million and exit non-core businesses, with expected annualized margin improvements.
Cash conversion target set at or above 70%, with CapEx expected to moderate after recent investments; progressive dividend policy maintained, with potential for buybacks or special dividends.
Engineering, distribution, and admin costs targeted at 12%, 18%, and 10% of revenue, respectively.
Business Segmentation and Market Focus
Business reorganized into three new reporting segments: Industrial Metrology, Position Measurement, and Specialized Technologies, aligning with customer end markets and effective FY26.
Each segment contains a mix of established and emerging product lines, with profit targets applied to the main segments.
Specialized Technologies segment includes independent product lines and non-core businesses slated for divestment.
Growth strategies emphasize market share gains through innovation, especially in semiconductors, automation, and robotics, with #1 or #2 positions in core markets.
Increased investment in Asia, particularly China and India, while reducing resource allocation in EMEA due to market challenges; sales resource alignment and specialist teams for key business units.
Latest events from Renishaw
- Record H1 revenue and margin gains set a strong outlook despite currency and EMEA headwinds.RSW
H1 202611 Feb 2026 - Record revenue and strong H2, but profit fell; FY2025 outlook is positive.RSW
H2 202420 Jan 2026 - Revenue growth and new products support margin recovery and improved outlook for FY2025.RSW
H2 2024 (Q&A)20 Jan 2026 - Revenue and profit rose 3% and 9%, with strong cash flow and a positive FY2025 outlook.RSW
H1 2025 (Q&A)17 Dec 2025 - Revenue and profit rose 3% and 9% respectively, with a strong outlook and robust cash flow.RSW
H1 202517 Dec 2025 - Q1 FY2026 revenue rose 2.8% at constant currency, led by Americas and APAC growth.RSW
Q1 2026 TU23 Oct 2025 - Record revenue and profit growth achieved, driven by innovation and strong cash generation.RSW
H2 2025 (Q&A)18 Sep 2025 - Record revenue, margin stability, and innovation drive steady growth outlook amid cost actions.RSW
H2 202518 Sep 2025 - Revenue and profit rose, with growth in manufacturing technologies and a cautious outlook.RSW
Trading Update13 Jun 2025